These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2373194)

  • 1. Exogenous fibronectin modifies the aggregation of collagen-stimulated human platelets.
    Eynard AR; Pasqualini ME; Rovasio RA
    Experientia; 1990 Jul; 46(7):680-2. PubMed ID: 2373194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitory effect of plasma fibronectin on collagen-induced platelet aggregation.
    Moon DG; Kaplan JE; Mazurkewicz JE
    Blood; 1986 Feb; 67(2):450-7. PubMed ID: 3942831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on fibronectin and its domains. I. Novel recombinant cell-binding domain of fibronectin--a modulator of human platelet functions.
    Vogel T; Werber MM; Guy R; Levanon A; Nimrod A; Legrand C; Gorecki M; Eldor A; Panet A
    Arch Biochem Biophys; 1993 Jan; 300(1):501-9. PubMed ID: 8424687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibronectin unfolded by adherent but not suspended platelets: An in vitro explanation for its dual role in haemostasis.
    Huynh K; Gyenes M; Hollenberg CP; Nguyen TH; Van Vo T; Stoldt VR
    Thromb Res; 2015 Oct; 136(4):803-12. PubMed ID: 26277681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma fibronectin-C1q complex formation and its effect on C1q inhibition of collagen-induced platelet aggregation.
    Wautier JL; Wautier MP; Kadeva H; Mosesson MW
    Thromb Res; 1983 Nov; 32(3):283-90. PubMed ID: 6606861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of fibronectin, Von Willebrand factor, and fibrinogen in platelet interaction with solid substrata.
    Lahav J; Hynes RO
    J Supramol Struct Cell Biochem; 1981; 17(4):299-311. PubMed ID: 6977039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dependence of the thrombocyte aggregation reaction on plasma fibronectin and the tripeptide arginyl-glycyl-asparagilin].
    Iuranek IO; Fedorov NA; Titov MI; Deĭgin VI
    Biull Eksp Biol Med; 1989 May; 107(5):536-7. PubMed ID: 2736279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the existence and biological role of L-arginine/nitric oxide pathway in human platelets by spin-trapping/EPR studies.
    Prónai L; Ichimori K; Nozaki H; Nakazawa H; Okino H; Carmichael AJ; Arroyo CM
    Eur J Biochem; 1991 Dec; 202(3):923-30. PubMed ID: 1662618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibronectin is required for platelet adhesion and for thrombus formation on subendothelium and collagen surfaces.
    Bastida E; Escolar G; Ordinas A; Sixma JJ
    Blood; 1987 Nov; 70(5):1437-42. PubMed ID: 3663940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibronectin-mediated inhibition of human platelet activation by crosslinked immunoglobulin G.
    Spycher MO; Lerch PG; Nydegger UE
    Br J Haematol; 1986 Oct; 64(2):299-307. PubMed ID: 2946316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagen-platelet interaction: type XI collagen-induced platelet aggregation.
    Chiang TM; Cremer M; Kang AH
    Thromb Res; 1990 Aug; 59(3):509-20. PubMed ID: 2237823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of bupivacaine and pipecoloxylidide on platelet function in vitro.
    Odoom JA; Sturk A; Dokter PW; Bovill JG; ten Cate JW; Oosting J
    Acta Anaesthesiol Scand; 1989 Jul; 33(5):385-8. PubMed ID: 2529732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of human platelet function by food flavonoids.
    Kelly C; Hunter K; Crosbie L; Gordon MJ; Dutta-Roy AK
    Biochem Soc Trans; 1996 May; 24(2):197S. PubMed ID: 8736855
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of a potent platelet aggregation inhibitor from Agkistrodon rhodostoma snake venom.
    Huang TF; Wu YJ; Ouyang C
    Biochim Biophys Acta; 1987 Sep; 925(3):248-57. PubMed ID: 3620499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro adrenaline and collagen-induced mobilization of platelet calcium and its inhibition by naftopidil, doxazosin and nifedipine.
    Alarayyed NA; Cooper MB; Prichard BN; Betteridge DJ; Smith CC
    Br J Clin Pharmacol; 1997 Apr; 43(4):415-20. PubMed ID: 9146854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet interaction with the extracellular matrix produced by cultured endothelial cells: a model to study the thrombogenicity of isolated subendothelial basal lamina.
    Vlodavsky I; Eldor A; HyAm E; Atzom R; Fuks Z
    Thromb Res; 1982 Oct; 28(2):179-91. PubMed ID: 7179215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet interactions with heparin binding growth factor and fibronectin.
    Greisler HP; Klosak JJ; Steinam S; Burgess WH; Henderson SC; Cabusao EA; Ellinger J
    ASAIO Trans; 1989; 35(3):561-3. PubMed ID: 2597534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of platelet aggregation by a monoclonal antibody against human fibronectin.
    Dixit VM; Haverstick DM; O'Rourke K; Hennessy SW; Broekelmann TJ; McDonald JA; Grant GA; Santoro SA; Frazier WA
    Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3844-8. PubMed ID: 2582428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-1 inhibits platelet aggregation in vivo: a study with 111indium-labelled platelets.
    Thiemermann C; May GR; Page CP; Vane JR
    Br J Pharmacol; 1990 Feb; 99(2):303-8. PubMed ID: 2183912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma fibronectin and platelet aggregation in diabetes mellitus.
    Inoguchi T; Umeda F; Watanabe J; Wasada T; Ibayashi H
    Diabetes Res Clin Pract; 1986 May; 2(2):69-73. PubMed ID: 3720501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.